ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Gene Expression Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-13Z17135
Home | Market Reports | Science| Biological Sciences
Global RNA Gene Expression Sequencing Market Research Report 2024
BUY CHAPTERS

Global RNA Gene Expression Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13Z17135
Report
November 2025
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
Bio Rad
Agilent Technologies
Qiagen NV
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang biology
Novogene
Macrogen
Tsingke Biotechnology Co., Ltd.

RNA Gene Expression Sequencing Market

The global RNA Gene Expression Sequencing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
RNA gene expression sequencing is a high-throughput sequencing technology used to analyze the type and amount of RNA in cells or tissues to understand the expression patterns and levels of genes. Through RNA gene expression sequencing, comprehensive quantitative analysis of the transcriptome can be performed, including identifying the type and number of transcripts, detecting gene expression levels, and discovering new RNA species. This technology is of great significance for studying gene expression regulation, diagnosing diseases and discovering new drug targets.
From a downstream perspective, Biomedical Field accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
RNA Gene Expression Sequencing leading manufacturers including Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, etc., dominate supply; the top five capture approximately % of global revenue, with Illumina leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global RNA Gene Expression Sequencing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of RNA Gene Expression Sequencing Market Report

Report Metric Details
Report Name RNA Gene Expression Sequencing Market
Segment by Type
  • Total RNA
  • Noncoding RNA
Segment by Application
  • Biomedical Field
  • Non-medical Field
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, BGI Genomics, Zhijiang Biology, Novogene Co., Ltd, Macrogen, Tsingke Biotechnology Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the RNA Gene Expression Sequencing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the RNA Gene Expression Sequencing Market report?

Ans: The main players in the RNA Gene Expression Sequencing Market are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, BGI Genomics, Zhijiang Biology, Novogene Co., Ltd, Macrogen, Tsingke Biotechnology Co., Ltd.

What are the Application segmentation covered in the RNA Gene Expression Sequencing Market report?

Ans: The Applications covered in the RNA Gene Expression Sequencing Market report are Biomedical Field, Non-medical Field

What are the Type segmentation covered in the RNA Gene Expression Sequencing Market report?

Ans: The Types covered in the RNA Gene Expression Sequencing Market report are Total RNA, Noncoding RNA

1 Study Coverage
1.1 Introduction to RNA Gene Expression Sequencing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global RNA Gene Expression Sequencing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Total RNA
1.2.3 Noncoding RNA
1.3 Market Segmentation by Application
1.3.1 Global RNA Gene Expression Sequencing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global RNA Gene Expression Sequencing Revenue Estimates and Forecasts 2020-2031
2.2 Global RNA Gene Expression Sequencing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global RNA Gene Expression Sequencing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global RNA Gene Expression Sequencing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Total RNA Market Size by Players
3.3.2 Noncoding RNA Market Size by Players
3.4 Global RNA Gene Expression Sequencing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global RNA Gene Expression Sequencing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global RNA Gene Expression Sequencing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America RNA Gene Expression Sequencing Market Size by Type (2020-2031)
6.4 North America RNA Gene Expression Sequencing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America RNA Gene Expression Sequencing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe RNA Gene Expression Sequencing Market Size by Type (2020-2031)
7.4 Europe RNA Gene Expression Sequencing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe RNA Gene Expression Sequencing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific RNA Gene Expression Sequencing Market Size by Type (2020-2031)
8.4 Asia-Pacific RNA Gene Expression Sequencing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific RNA Gene Expression Sequencing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America RNA Gene Expression Sequencing Market Size by Type (2020-2031)
9.4 Central and South America RNA Gene Expression Sequencing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America RNA Gene Expression Sequencing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa RNA Gene Expression Sequencing Market Size by Type (2020-2031)
10.4 Middle East and Africa RNA Gene Expression Sequencing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa RNA Gene Expression Sequencing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina RNA Gene Expression Sequencing Product Features and Attributes
11.1.4 Illumina RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.1.5 Illumina RNA Gene Expression Sequencing Revenue by Product in 2024
11.1.6 Illumina RNA Gene Expression Sequencing Revenue by Application in 2024
11.1.7 Illumina RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.1.8 Illumina RNA Gene Expression Sequencing SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific RNA Gene Expression Sequencing Product Features and Attributes
11.2.4 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific RNA Gene Expression Sequencing SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Corporation Information
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad RNA Gene Expression Sequencing Product Features and Attributes
11.3.4 Bio-Rad RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.3.5 Bio-Rad RNA Gene Expression Sequencing Revenue by Product in 2024
11.3.6 Bio-Rad RNA Gene Expression Sequencing Revenue by Application in 2024
11.3.7 Bio-Rad RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.3.8 Bio-Rad RNA Gene Expression Sequencing SWOT Analysis
11.3.9 Bio-Rad Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Corporation Information
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies RNA Gene Expression Sequencing Product Features and Attributes
11.4.4 Agilent Technologies RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.4.5 Agilent Technologies RNA Gene Expression Sequencing Revenue by Product in 2024
11.4.6 Agilent Technologies RNA Gene Expression Sequencing Revenue by Application in 2024
11.4.7 Agilent Technologies RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.4.8 Agilent Technologies RNA Gene Expression Sequencing SWOT Analysis
11.4.9 Agilent Technologies Recent Developments
11.5 QIAGEN
11.5.1 QIAGEN Corporation Information
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN RNA Gene Expression Sequencing Product Features and Attributes
11.5.4 QIAGEN RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.5.5 QIAGEN RNA Gene Expression Sequencing Revenue by Product in 2024
11.5.6 QIAGEN RNA Gene Expression Sequencing Revenue by Application in 2024
11.5.7 QIAGEN RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.5.8 QIAGEN RNA Gene Expression Sequencing SWOT Analysis
11.5.9 QIAGEN Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Business Overview
11.6.3 Roche RNA Gene Expression Sequencing Product Features and Attributes
11.6.4 Roche RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.6.5 Roche Recent Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Corporation Information
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences RNA Gene Expression Sequencing Product Features and Attributes
11.7.4 Pacific Biosciences RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.7.5 Pacific Biosciences Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Corporation Information
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Gene Expression Sequencing Product Features and Attributes
11.8.4 Eurofins Scientific RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.8.5 Eurofins Scientific Recent Developments
11.9 Azenta
11.9.1 Azenta Corporation Information
11.9.2 Azenta Business Overview
11.9.3 Azenta RNA Gene Expression Sequencing Product Features and Attributes
11.9.4 Azenta RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.9.5 Azenta Recent Developments
11.10 LabCorp
11.10.1 LabCorp Corporation Information
11.10.2 LabCorp Business Overview
11.10.3 LabCorp RNA Gene Expression Sequencing Product Features and Attributes
11.10.4 LabCorp RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Corporation Information
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics RNA Gene Expression Sequencing Product Features and Attributes
11.11.4 BGI Genomics RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.11.5 BGI Genomics Recent Developments
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Corporation Information
11.12.2 Zhijiang Biology Business Overview
11.12.3 Zhijiang Biology RNA Gene Expression Sequencing Product Features and Attributes
11.12.4 Zhijiang Biology RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.12.5 Zhijiang Biology Recent Developments
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Corporation Information
11.13.2 Novogene Co., Ltd Business Overview
11.13.3 Novogene Co., Ltd RNA Gene Expression Sequencing Product Features and Attributes
11.13.4 Novogene Co., Ltd RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.13.5 Novogene Co., Ltd Recent Developments
11.14 Macrogen
11.14.1 Macrogen Corporation Information
11.14.2 Macrogen Business Overview
11.14.3 Macrogen RNA Gene Expression Sequencing Product Features and Attributes
11.14.4 Macrogen RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.14.5 Macrogen Recent Developments
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Corporation Information
11.15.2 Tsingke Biotechnology Co., Ltd. Business Overview
11.15.3 Tsingke Biotechnology Co., Ltd. RNA Gene Expression Sequencing Product Features and Attributes
11.15.4 Tsingke Biotechnology Co., Ltd. RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.15.5 Tsingke Biotechnology Co., Ltd. Recent Developments
12 RNA Gene Expression SequencingIndustry Chain Analysis
12.1 RNA Gene Expression Sequencing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 RNA Gene Expression Sequencing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global RNA Gene Expression Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
Bio Rad
Agilent Technologies
Qiagen NV
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang biology
Novogene
Macrogen
Tsingke Biotechnology Co., Ltd.
List of Tables
 Table 1. Global RNA Gene Expression Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global RNA Gene Expression Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global RNA Gene Expression Sequencing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global RNA Gene Expression Sequencing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global RNA Gene Expression Sequencing Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global RNA Gene Expression Sequencing Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global RNA Gene Expression Sequencing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Gene Expression Sequencing as of 2024)
 Table 11. Global RNA Gene Expression Sequencing Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global RNA Gene Expression Sequencing Companies Headquarters
 Table 13. Global RNA Gene Expression Sequencing Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global RNA Gene Expression Sequencing Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global RNA Gene Expression Sequencing Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global RNA Gene Expression Sequencing Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global RNA Gene Expression Sequencing Revenue by Application (2026-2031) & (US$ Million)
 Table 21. RNA Gene Expression Sequencing High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America RNA Gene Expression Sequencing Growth Accelerators and Market Barriers
 Table 25. North America RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe RNA Gene Expression Sequencing Growth Accelerators and Market Barriers
 Table 27. Europe RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific RNA Gene Expression Sequencing Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America RNA Gene Expression Sequencing Investment Opportunities and Key Challenges
 Table 31. Central and South America RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa RNA Gene Expression Sequencing Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Illumina Corporation Information
 Table 35. Illumina Description and Major Businesses
 Table 36. Illumina Product Features and Attributes
 Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Illumina Revenue Proportion by Product in 2024
 Table 39. Illumina Revenue Proportion by Application in 2024
 Table 40. Illumina Revenue Proportion by Geographic Area in 2024
 Table 41. Illumina RNA Gene Expression Sequencing SWOT Analysis
 Table 42. Illumina Recent Developments
 Table 43. Thermo Fisher Scientific Corporation Information
 Table 44. Thermo Fisher Scientific Description and Major Businesses
 Table 45. Thermo Fisher Scientific Product Features and Attributes
 Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 50. Thermo Fisher Scientific RNA Gene Expression Sequencing SWOT Analysis
 Table 51. Thermo Fisher Scientific Recent Developments
 Table 52. Bio-Rad Corporation Information
 Table 53. Bio-Rad Description and Major Businesses
 Table 54. Bio-Rad Product Features and Attributes
 Table 55. Bio-Rad Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Bio-Rad Revenue Proportion by Product in 2024
 Table 57. Bio-Rad Revenue Proportion by Application in 2024
 Table 58. Bio-Rad Revenue Proportion by Geographic Area in 2024
 Table 59. Bio-Rad RNA Gene Expression Sequencing SWOT Analysis
 Table 60. Bio-Rad Recent Developments
 Table 61. Agilent Technologies Corporation Information
 Table 62. Agilent Technologies Description and Major Businesses
 Table 63. Agilent Technologies Product Features and Attributes
 Table 64. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Agilent Technologies Revenue Proportion by Product in 2024
 Table 66. Agilent Technologies Revenue Proportion by Application in 2024
 Table 67. Agilent Technologies Revenue Proportion by Geographic Area in 2024
 Table 68. Agilent Technologies RNA Gene Expression Sequencing SWOT Analysis
 Table 69. Agilent Technologies Recent Developments
 Table 70. QIAGEN Corporation Information
 Table 71. QIAGEN Description and Major Businesses
 Table 72. QIAGEN Product Features and Attributes
 Table 73. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. QIAGEN Revenue Proportion by Product in 2024
 Table 75. QIAGEN Revenue Proportion by Application in 2024
 Table 76. QIAGEN Revenue Proportion by Geographic Area in 2024
 Table 77. QIAGEN RNA Gene Expression Sequencing SWOT Analysis
 Table 78. QIAGEN Recent Developments
 Table 79. Roche Corporation Information
 Table 80. Roche Description and Major Businesses
 Table 81. Roche Product Features and Attributes
 Table 82. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Roche Recent Developments
 Table 84. Pacific Biosciences Corporation Information
 Table 85. Pacific Biosciences Description and Major Businesses
 Table 86. Pacific Biosciences Product Features and Attributes
 Table 87. Pacific Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Pacific Biosciences Recent Developments
 Table 89. Eurofins Scientific Corporation Information
 Table 90. Eurofins Scientific Description and Major Businesses
 Table 91. Eurofins Scientific Product Features and Attributes
 Table 92. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Eurofins Scientific Recent Developments
 Table 94. Azenta Corporation Information
 Table 95. Azenta Description and Major Businesses
 Table 96. Azenta Product Features and Attributes
 Table 97. Azenta Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Azenta Recent Developments
 Table 99. LabCorp Corporation Information
 Table 100. LabCorp Description and Major Businesses
 Table 101. LabCorp Product Features and Attributes
 Table 102. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. LabCorp Recent Developments
 Table 104. BGI Genomics Corporation Information
 Table 105. BGI Genomics Description and Major Businesses
 Table 106. BGI Genomics Product Features and Attributes
 Table 107. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. BGI Genomics Recent Developments
 Table 109. Zhijiang Biology Corporation Information
 Table 110. Zhijiang Biology Description and Major Businesses
 Table 111. Zhijiang Biology Product Features and Attributes
 Table 112. Zhijiang Biology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Zhijiang Biology Recent Developments
 Table 114. Novogene Co., Ltd Corporation Information
 Table 115. Novogene Co., Ltd Description and Major Businesses
 Table 116. Novogene Co., Ltd Product Features and Attributes
 Table 117. Novogene Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Novogene Co., Ltd Recent Developments
 Table 119. Macrogen Corporation Information
 Table 120. Macrogen Description and Major Businesses
 Table 121. Macrogen Product Features and Attributes
 Table 122. Macrogen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Macrogen Recent Developments
 Table 124. Tsingke Biotechnology Co., Ltd. Corporation Information
 Table 125. Tsingke Biotechnology Co., Ltd. Description and Major Businesses
 Table 126. Tsingke Biotechnology Co., Ltd. Product Features and Attributes
 Table 127. Tsingke Biotechnology Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Tsingke Biotechnology Co., Ltd. Recent Developments
 Table 129. Raw Materials Key Suppliers
 Table 130. Distributors List
 Table 131. Market Trends and Market Evolution
 Table 132. Market Drivers and Opportunities
 Table 133. Market Challenges, Risks, and Restraints
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources


List of Figures
 Figure 1. RNA Gene Expression Sequencing Product Picture
 Figure 2. Global RNA Gene Expression Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Total RNA Product Picture
 Figure 4. Noncoding RNA Product Picture
 Figure 5. Global RNA Gene Expression Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Biomedical Field
 Figure 7. Non-medical Field
 Figure 8. RNA Gene Expression Sequencing Report Years Considered
 Figure 9. Global RNA Gene Expression Sequencing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 11. Global RNA Gene Expression Sequencing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global RNA Gene Expression Sequencing Revenue Market Share by Region (2020-2031)
 Figure 13. Global RNA Gene Expression Sequencing Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Total RNA Revenue Market Share by Player in 2024
 Figure 16. Noncoding RNA Revenue Market Share by Player in 2024
 Figure 17. Global RNA Gene Expression Sequencing Revenue Market Share by Type (2020-2031)
 Figure 18. Global RNA Gene Expression Sequencing Revenue Market Share by Application (2020-2031)
 Figure 19. North America RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
 Figure 21. North America RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
 Figure 28. Europe RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 31. France RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 43. India RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
 Figure 51. Central and South America RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
 Figure 57. South America RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
 Figure 63. RNA Gene Expression Sequencing Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global RNA Sequencing Analysis Market Insights Forecast to 2030
Transcriptome Sequencing Based on RNA seq Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Sequencing
Global NGS based RNA sequencing Market Insights Forecast to 2030
Global RNA Sequencing Services Market Research Report 2024
mRNA Transcriptome Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Expression and Transcriptome Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Sequencing Technologies Market Insights Forecast to 2030
Global Spatial Transcriptomics Sequencing Market Research Report 2025
Global RNA Next Generation Sequencing Market Research Report 2024
RNA Analysis Transcriptomics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Sequencing Service Market Research Report 2024
Global Gene Sequencing Equipment and Service Market Research Report 2024
Global DNA Sequencing Equipment and Service Market Research Report 2024
Global Gene Expression Profiling Market Insights Forecast to 2030
Global Targeted RNA Sequencing Market Research Report 2025
Global Gene Expression Screening Service Market Research Report 2024
Global Single Cell RNA Sequencing Market Research Report 2025
Global Whole Transcriptomics Sequencing Market Insights Forecast to 2030
Gene Expression Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions